Ved terapeutiske doser af irbesartan hos mennesker synes hyperplasi/ hypertrofi af de renale juxtaglomerulære celler ikke at have nogen relevans.
For therapeutic doses of irbesartan in humans, the hyperplasia/ hypertrophy of the renal juxtaglomerular cells does not appear to have any relevance.